Inhibition of cellular esterases by the antitumour imidazotetrazines mitozolomide and temozolomide: demonstration by flow cytometry and conventional spectrofluorimetry C. DiveP. WorkmanJ. V. Watson OriginalPaper Pages: 149 - 155
Protection against cisplatin nephrotoxicity by prochlorperazine R. A. Kramer OriginalPaper Pages: 156 - 160
Influence of scheduling on two-drug combinations of alkylating agents in vivo Beverly A. TeicherSylvia A. HoldenTerence S. Herman OriginalPaper Pages: 161 - 166
Pharmacologic basis for the use of dipyridamole to increase the selectivity of intraperitoneally delivered methotrexate Rakesh GoelRaghuram SangaStephen B. Howell OriginalPaper Pages: 167 - 172
Synergy between 5,10-dideaza-5,6,7,8-tetrahydrofolic acid and methotrexate in mice bearing L1210 tumors K. FergusonD. BoschelliS. S. Kerwar OriginalPaper Pages: 173 - 176
Comparative uptake and retention of adriamycin andN-benzyladriamycin-14-valerate in human CEM leukemic lymphocyte cell cultures Mervyn IsraelTrevor W. SweatmanYoshihiro Koseki OriginalPaper Pages: 177 - 183
Isolation, identification and biological activity of a phyllanthoside metabolite produced in vitro by mouse plasma Dennis E. ChapmanDavid J. MooreGarth Powis OriginalPaper Pages: 184 - 188
6-Ethylmercaptopurine-mediated growth inhibition of HL-60 cells in vitro irrespective of purine salvage Diane S. GibboneyBernard T. FrenchRonald W. Trewyn OriginalPaper Pages: 189 - 194
Validated HPLC procedures for the analysis of BMY-28090 in human plasma and urine Robert C. GaverGeorge DeebAlice M. George OriginalPaper Pages: 195 - 201
A phase II study of carboplatin and vincristine in previously treated patients with small-cell lung cancer Egbert F. SmitHenk H. BerendsenPieter E. Postmus OriginalPaper Pages: 202 - 204
Characterization of the anti-tumour activity against solid tumours of a new nitrosoureido sugar: Cy 233 G. AtassiP. DumontP. Roger OriginalPaper Pages: 205 - 209
Effect of etoposide (VP16-213) on lipid peroxidation and antioxidant status in a high-dose radiochemotherapy regimen Claudia LadnerGerhard EhningerMichael R. Clemens OriginalPaper Pages: 210 - 212
Haematological recovery following high-dose cyclophosphamide with autologous bone marrow transplantation Christopher TwelvesRobert SouhamiAnthony Goldstone OriginalPaper Pages: 213 - 218
A pharmacological evaluation of a new 3-month depot preparation of buserelin for prostatic cancer J. WaxmanJ. SandowG. Williams Short Communication Pages: 219 - 220
Reduction of B16 melanoma metastases by oral administration of egg-white lysozyme Gianni Sava Short Communication Pages: 221 - 222
Phase II trial of plicamycin and hydroxyurea in acute myelogenous leukemia Eric ArchimbaudJacques TroncyDenis Fiere Short Communication Pages: 223 - 225